myelomeningocele

A myelomeningocele should be closed within 24 hours of birth to prevent infection.

Hydrocephalus ("water on the brain") develops in about 70% of patients with myelomeningocele.

Her myelomeningocele required her to have 21 surgical operations by the time she was ten years old.

It is also used to treat spina bifida and myelomeningocele.

The terms spina bifida and myelomeningocele are usually used interchangeably.

Most individuals with myelomeningocele will need periodic evaluations by a variety of specialists:

Spina bifida with myeloschisis is the most severe form of myelomeningocele.

Such reactions account for a significant proportion of perioperative anaphylactic reaction, especially in children with myelomeningocele.

The seven patients who received the tissue-engineered bladders were born with a spinal defect known as myelomeningocele.

His specialty is pediatric urologic reconstruction and the urologic care of patients with myelomeningocele.

This includes meningocele and myelomeningocele.

If the baby has fluid build-up in the brain, a shunt is usually put in when the myelomeningocele is repaired.

In individuals with myelomeningocele, the unfused portion of the spinal column allows the spinal cord to protrude through an opening.

Clinical research includes a randomized clinical trial comparing prenatal surgical repair of myelomeningocele to standard postnatal care.

Children with myelomeningocele and bladder exstrophy as well as children with cystic fibrosis are particularly at risk.

Spina Bifida (Myelomeningocele)

Spina bifida, or myelomeningocele is a type of open neural tube defect that can occur with problems with the early development of a fetus.

The corpus callosum is abnormally developed in 70-90% of individuals with spina bifida myelomeningocele; this impacts the communication processes between the left and right brain hemispheres.

In February 2003, the National Institutes of Health began the Management of Myelomeningocele Study (MOMS).

Fetal closure of neural tube defects is an option for some families as part of the Management of Myelomeningocele Study (MOMS) in the United States.

Some swimming, movement and sports groups cater for a wide range of disabilities including impaired limbs, spina bifida, multiple sclerosis, epilepsy, cystic fibrosis, Down's syndrome, myelomeningocele, arthritis and accident injuries.

In about 90% of the people with myelomeningocele, hydrocephalus also occurs because the displaced cerebellum interferes with the normal flow of cerebrospinal fluid, causing an excess of the fluid to accumulate.

Spina bifida malformations fall into three categories: spina bifida occulta, spina bifida cystica with meningocele, and spina bifida cystica with myelomeningocele.

Management of Myelomeningocele Study (MOMS) is a phase III clinical trial to evaluate the safety and efficacy of fetal surgery to close a myelomeningocele.

In 2001 Dr. Martinez-Ferro along with the CEMIC Surgical and Obstetrical Team performed the first fetal surgery in a patient with myelomeningocele in Argentina.